Medovex called on Russo Partners, a public relations and corporate communications company, to increase awareness about chronic back pain treatments, highlighting Medovex's DenerveX System, according to Markets Insider.
Here are four things to know:
1. The DenerveX System is intended to relieve pain from facet joint syndrome by denervating and removing capsular tissue from the joint.
2. Medovex is releasing a video campaign in which spine surgeons around the global share their thoughts on using the system. The campaign also includes a demonstration of the system in a cadaver lab.
3. Russo Partners will use the campaign content for social and traditional medical initiatives.
4. The system is not yet approved in the U.S.
More articles on devices:
40 orthopedic devices receive FDA 510(k) clearance in October
Mazor, J&J, Globus Medical & more: 6 device company notes
Titan Medical reports $4M in research, development expenses in Q3 2017: 4 notes